GI/endoscopy company stock report – March 27, 2015

Here is a stock report on five publicly traded GI/endoscopy companies for March 23 to March 27.

Advertisement

•    AbbVie: $57.61 per share (up 0.63 percent)
•    Boston Scientific: $17.73 per share (up 1.66 percent)
•    FUJIFILM Holdings: 4,213.50 per share (JPY) (down 0.85 percent)
•    Olympus: 4,450 per share (JPY) (down 0.22 percent)
•    Salix Pharmaceuticals: $172.74 per share (up 0.06 percent)

More articles on gastroenterology:
Dr. Atif Iqbal: Using the LINX device for GERD treatment
6 reasons patients avoid undergoing screening colonoscopy
GI physician leader to know: Dr. Gary Gitnick of University of California, Los Angeles

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.